Medication Safety Alerts

In addition to a full suite of medication safety newsletters for healthcare professionals and consumers, ISMP makes available urgent medication advisories. These Safety Alerts address serious medication errors or information requiring immediate attention by healthcare practitioners.

ISMP Alerts

ISMP collects and analyzes thousands of medication error and adverse event reports each year, including through its voluntary ISMP National Medication Errors Reporting Program (ISMP MERP), National Vaccine Errors Reporting Program (ISMP VERP), and consumer medication error reporting program (ISMP C-MERP). ISMP issues alerts through its many communication channels to share emerging information on errors happening across the nation, “lessons learned,” and prevention strategies with the entire healthcare community.

NAN Alerts

从2009年开始,ISMP加入了美国卫生系统药剂师学会(ASHP)和国家药物错误报告与预防委员会(NCC MERP)的其他成员,以创建国家警报网络(NAN)。NAN通过几个国家分销渠道警告医疗保健提供者,了解最近造成严重伤害或死亡的实际药物错误或潜在用药错误。警报基于提交给ISMP MERP的信息。

FDA Alerts

Periodically, the US Food and Drug Administration (FDA) issues alerts related to medication recalls, increased incidence of adverse events for certain medications, and recommendations for reducing naming or packaging errors.

PSA Advisories

The Pennsylvania Patient Safety Authority (PSA) publishes a quarterly advisory to provide additional guidance on specific issues related to distribution and use of medications.

Fresenius Kabi USA is voluntarily recalling lot 6400048 (expires July 2018) of Midazolam Injection, USP, 2 mg/2 mL packaged in...